Progress in mitral and aortic regurgitation

Progress in Cardiovascular Diseases

Volumn 43, Issue 6, 2001, Pages 457-475

  Carabello, Blase A ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE REGURGITATION; DISEASE SEVERITY; HEART CATHETERIZATION; HUMAN; LONGEVITY; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; REVIEW; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT PLANNING; VALVULAR HEART DISEASE;

EID: 0034953874     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2001.24597     Document Type: Article

References (76)

1. Pathology of mitral valve stenosis and pure mitral regurgitation: Part II
2. Mechanism of ischemic mitral regurgitation. An experimental evaluation
3. Distortions of the mitral valve in acute ischemic mitral regurgitation
4. Three-dimensional dynamics of the canine mitral annulus during ischemic mitral regurgitation
5. Papillary muscle rupture and fatal acute myocardial infarction
6. Papillary muscle rupture complicating acute myocardial infraction: Analysis of 17 patients
7. Evidence for progression from mild to severe mitral regurgitation in mitral valve prolapse
8. Clinical outcome of mitral regurgitation due to flail leaflets
9. Mitral regurgitation, part 1: Basic pathophysiologic principles
10. Chronic mitral regurgitation: Predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress
11. Temporal response of left ventricular performance to mitral valve surgery
12. Assessment of preoperative left ventricular function in patients with mitral regurgitation: Value of the end-systolic wall stress-end-systolic volume ratio
13. Forskolin reverses the force-frequency defect in left ventricular subepicardium (EPI) but not in papillary myocardium in human mitral regurgitation heart failure
14. Structural basis for changes in left ventricular function and geometry because of chronic mitral regurgitation and after correction of volume overload
15. Cellular and ventricular contractile dysfunction in experimental canine mitral regurgitation
16. Depressed contractile function due to canine mitral regurgitation improves after correction of the volume overload
17. Left ventricular mechanics and myocyte function after correction of experimental chronic mitral regurgitation by combined mitral valve replacement and preservation of the native mitral valve apparatus
18. Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation
19. Effects of valve surgery on left ventricular contractile function in patients with long-term mitral regurgitation
20. Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin
21. Adrenergic effects on the biology of the adult mammalian cardiocyte
22. The pathophysiology of mitral regurgitation
23. The relationship of left ventricular geometry and hypertrophy to left ventricular function in valvular heart disease
24. The relationship of afterload to ejection performance in chronic mitral regurgitation
25. Left ventricular hypertrophy due to volume overload versus pressure overload
26. Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload
27. Mechanisms of cardiac hypertrophy in canine volume overload
28. Left ventricular hypertrophy in mitral regurgitation is not driven by abnormal myocardial protein synthesis rates
29. Effects of left ventricular volume overload produced by mitral regurgitation on diastolic function
30. Left ventricular passive diastolic properties in chronic mitral regurgitation
31. Impact of impinging wall jet on color Doppler quantification of mitral regurgitation
32. Instrumentation and physical factors related to visualization of stenotic and regurgitant jets by Doppler color flow mapping
33. Color Doppler assessment of mitral regurgitation with orthogonal planes
34. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: Angiographic and hemodynamic correlations
35. Spatial velocity distribution and acceleration in serial subvalve tunnel and valvular obstructions: An in vitro study using Doppler color flow mapping
36. A new method for quantification of regurgitant flow rate using color Doppler flow imaging of the flow convergence region proximal to a discrete orifice: An in vitro study
37. A new method for quantification of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice
38. Application of color Doppler flow mapping to calculate effective regurgitant orifice area: An in vitro study and initial clinical observations
39. Effective mitral regurgitant orifice area: Clinical use and pitfalls of the proximal isovelocity surface area method
40. Assessment of mitral regurgitation by Doppler color flow mapping of the vena contracta
41. Effective regurgitant orifice area: A noninvasive Doppler development of an old hemodynamic concept
42. Limitations of pulmonary wedge V waves in diagnosing mitral regurgitation
43. Diagnostic and therapeutic considerations in acute, severe mitral regurgitation: Experience in 42 consecutive patients entering the intensive care unit with pulmonary edema
44. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation
45. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function
46. Effects of exercise on left ventricular performance determined by echocardiography in chronic, severe mitral regurgitation secondary to mitral valve prolapse
47. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation
48. Sudden death in mitral regurgitation due to flail leaflet
49. Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance
50. Restoration of left ventricular systolic performance after reattachment of the mitral chordae tendineae. The importance of valvular-ventricular interaction
51. Mitral valve replacement for mitral regurgitation with or without preservation of chordae tendineae
52. Comparative assessment of chordal preservation versus chordal resection during mitral valve replacement
53. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation: Mechanism for differences in postoperative ejection performance
54. Valve repair in rheumatic mitral disease: An unsolved problem
55. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation
56. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation
57. Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty
58. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators
59. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction
60. Mitral valve reconstruction in elderly, ischemic patients
61. The effect of pathophysiology on the surgical treatment of ischemic mitral regurgitation: Operative and late risks of repair versus replacement
62. Pathology of aortic valve stenosis and pure aortic regurgitation: II: A clinical morphologic assessment
63. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation
64. Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: A prospective two-dimensional echocardiographic study
65. Ultrafast computed tomography analysis of regional radius-to-wall thickness ratios in normal and volume-overloaded human left ventricle
66. Angina pectoris and coronary artery disease in severe aortic regurgitation
67. Quantification of aortic regurgitation utilizing continuous wave Doppler ultrasound
68. Surgery for aortic regurgitation in women: Contrasting indications and outcomes compared with men
69. Observations on the optimum time for operative intervention for aortic regurgitation: I: Evaluation of the results of aortic valve replacement in symptomatic patients
70. Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function
71. Predictors of outcome in patients with aortic regurgitation and left ventricular dysfunction: A change in the measuring stick
72. Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance
73. Assessing the hemodynamic severity of acute aortic regurgitation and normal left ventricular function
74. Contribution of echocardiography and immediate surgery to the management of severe aortic regurgitation from active infective endocarditis
75. Cardiac operations during active endocarditis
76. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function